Skip to Content
  • An Approval Like No Other

    Merck got an unusual approval at the FDA recently, for its Keytruda antibody in oncology. What’s new about it is that it is the first approval that’ Read More
  • Turmoil in Immuno-oncology

    Immuno-oncology! It’s such a big deal, let’s just do what everyone in the field is doing and call it “IO”. The recent successes in this… Read More
  • Kite’s Latest News

    Readers will surely recall the problems that surfaced last year with Juno’s CAR-T cell therapy program. There were a number of patient deaths, and worried… Read More
  • PARP Inhibitors Do It Again

    When we last looked in on the long-running saga of PARP inhibitors around here, Tesaro had posted excellent clinical results for their compound and re-invigorat… Read More
  • Nativis Lives the Life

    I sort of hate to bring them up again, but a reader sent along this link to a story at Geekwire, all about how there’s a Seattle company has raised $10 mi… Read More
Page 1 of 3612345...102030...Last »